Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06505278 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy

Name: The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy — clinical trial record (NCT06505278)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusUnknown

PhasePhase 2

SponsorSun Yat-sen University

Started2024-08

View on ClinicalTrials.gov ↗

Record status

This record was last updated August 5, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06

Trial status changed: Not Yet Recruiting → Unknown

2024-08-01

Not Yet Recruiting→Unknown Study Status, Arms and Interventions, Outcome Measures v1

Trial statusNot Yet Recruiting→Unknown

Start date2024-07→2024-08

Secondary endpointsdetails revised at 1 of 9 entries

2024-07-10

Original filing

Sun Yat-sen University

609 trials monitored

See 13 trials at risk

Prostate Cancer

2,471 trials monitored

See 156 trials at risk

The purpose of this study is to assess the impact of medication timing adjustment on the effect of novel hormonal therapy (NHT) agents in patients with metastatic hormone-sensitive prostate cancer (mHSPC). The half of the patients will receive NHT agents in the morning, and the other half will receive NHT agents in the evening.

Trial Details

NCT Number	NCT06505278
Lead Sponsor	Sun Yat-sen University
Conditions	Prostate Cancer
Enrollment	70 participants
Start Date	2024-08
Primary Completion	2025-03 (estimated)
Study Completion	2025-12 (estimated)
Updated on ClinicalTrials.gov	2024-08-05